Search results
Worst is over for Apple, AI strategy pivotal to bullish outlook- Wedbush
Investing.com· 3 hours agoInvesting.com-- Wedbush analysts said that the worst was over for Apple Inc (NASDAQ: AAPL ) after...
Grand Theft Auto VI delays lead to Take-Two earnings downgrade
Proactive Investors· 5 days agoWedbush Securities has revised down its financial forecasts for Take-Two Interactive Software Inc...
Carvana Co. (NYSE:CVNA) to Post Q2 2024 Earnings of ($0.06) Per Share, Wedbush Forecasts
ETF DAILY NEWS· 6 hours agoCarvana Co. (NYSE:CVNA – Free Report) – Equities researchers at Wedbush lifted their Q2 2024 EPS...
Wedbush Weighs in on Chimerix, Inc.’s Q2 2024 Earnings (NASDAQ:CMRX)
ETF DAILY NEWS· 6 hours agoChimerix, Inc. (NASDAQ:CMRX – Free Report) – Equities researchers at Wedbush decreased their Q2 2024 earnings per share estimates for Chimerix in a report released on Wednesday ...
Texas Roadhouse, Inc. to Post Q2 2024 Earnings of $1.54 Per Share, Wedbush Forecasts (NASDAQ:TXRH)
ETF DAILY NEWS· 7 hours agoTexas Roadhouse, Inc. (NASDAQ:TXRH – Free Report) – Equities research analysts at Wedbush lifted...
AXT (NASDAQ:AXTI) Given Outperform Rating at Wedbush
ETF DAILY NEWS· 5 hours agoWedbush reiterated their outperform rating on shares of AXT (NASDAQ:AXTI – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $6.00 ...
Wedbush Analysts Cut Earnings Estimates for DoorDash, Inc. (NASDAQ:DASH)
ETF DAILY NEWS· 6 hours agoDoorDash, Inc. (NASDAQ:DASH – Free Report) – Analysts at Wedbush dropped their Q2 2024 earnings per share estimates for shares of DoorDash in a research note issued to investors ...
Wedbush maintains Outperform on Palantir stock By Investing.com
Investing.com· 20 hours agoOn Monday, ahead of Palantir Technologies Inc .'s (NYSE:PLTR) quarterly report, Wedbush maintained...
Healthpeak Properties upgraded to Outperform at Wedbush (NYSE:DOC-DEFUNCT-107152)
Seeking Alpha· 4 days agoThe article discusses Wedbush's upgrade of Healthpeak Properties (DOC) shares and their positive...
Q2 2024 EPS Estimates for Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Decreased by Analyst
ETF DAILY NEWS· 6 hours agoNeurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Stock analysts at Wedbush dropped their Q2 2024 earnings per share estimates for shares of Neurocrine Biosciences ...